CGEN
Compugen
2.40$
+0.9%
vs. previous close
Closing price · As of: Sep 29, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | -92.4% | +161.9% | +155.6% | -91.4% | +55.3% | -45.0% | +50.4% | +3,460.7% | -96.8% | +19.6% | – | |
| – | – | +4.9% | -26.2% | +132.0% | -81.3% | +255.6% | -30.6% | -0.9% | +114.3% | -48.4% | +47.7% | – | |
| – | – | -98.5% | +1,026.9% | +162.7% | -94.1% | -114.6% | – | – | +26,371.4% | -99.4% | -126.1% | – | |
| – | +31.1% | -41.3% | -3.5% | +2.0% | -6.3% | -2.3% | -2.3% | +2.8% | -4.4% | +25.1% | -9.1% | – | |
| – | +9.2% | -1.4% | -9.2% | +15.6% | -14.3% | +7.5% | -5.4% | -2.0% | -4.8% | +10.0% | -1.7% | – | |
| – | +26.8% | -33.6% | -4.3% | +5.5% | -8.4% | +0.0% | -3.1% | +1.4% | -4.7% | +20.8% | -6.7% | – | |
| – | – | -147.2% | – | – | -266.4% | – | – | – | – | -116.1% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | -138.8% | – | – | -205.8% | – | – | – | – | -113.5% | – | – | |
| – | +22,650.5% | -100.0% | +266.7% | +40,845.5% | -99.9% | +675.0% | -154.8% | – | – | – | +40.0% | – | |
| – | – | -174.8% | – | – | -579.4% | – | – | – | – | -113.5% | – | – | |
| – | – | -138.7% | – | – | -205.8% | – | – | – | – | -113.5% | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 29, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.